Article
PRESS RELEASES
Totus Medicines to Present at 2022 J.P. Morgan HealthCare Conference
01.11.2022

In the presentation, Dhawan will discuss Totus Medicines' proprietary drug discovery platform and first drug program, TOS-358, targeting the PI3Kα mutation, which impacts more than 500,000 people in the U.S. every year and drives a significant percentage of breast, colon, lung, bladder, stomach, and other cancers.
View Press Release